- Resource
- Source: Campus Sanofi
- 15 Jul 2026
Managing DUPIXENT (dupilumab) Related Adverse Events: An Expert Explains Series
Explore our Expert Explains series where leading dermatologists from across the UK share their experience with managing Dupixent related adverse events in clinical practice. Hear from Dr Amy Foulkes (Consultant Dermatologist) and Dr Felicity Ferguson (Guys & St Thomas’s) on how they have addressed ocular surface disorder (OSD) and facial erythema in their patients.
Managing OSD on DUPIXENT with Dr Amy Foulkes
8 mins
Recorded at AAD 2026, Denver. In this video, Dr Foulkes answers a variety of key questions related to OSD including how often it presents, her management approach and how to discuss the topic with patients during a consultation. Timestamps for each question are provided during the first few seconds of the video to help you navigate to specific questions that may be of interest.
Managing Facial Erythema on DUPIXENT with Dr Felicity Ferguson
4 mins
Recorded at AAD 2026, Denver. In this video, Dr Ferguson answers a variety of key questions related to facial erythema including how often it presents, the different types of erythema and her approach to treatment and long-term management. Timestamps for each question are provided during the first few seconds of the video to help you navigate to specific questions that may be of interest.
Discover other resources
Atopic Dermatitis Control Test (ADCT)
Atopic dermatitis, a type of eczema, may be affecting your patient’s life in more ways than you know.
The ADCT gives a measure of how controlled your patient’s eczema is. Use these 6 concise questions to evaluate all dimensions of atopic dermatitis control.
Development of ADCT involved literature review as well as interviews with patients and physicians, and was funded by Sanofi and Regeneron.
Try the ADCTMAT-XU-2602249 (v2.0) Date of Preparation: July 2026